| Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform M Pinto, V Silva, S Barreiro, R Silva, F Remião, F Borges, C Fernandes Ageing Research Reviews 79, 101658, 2022 | 44 | 2022 |
| Development of a PEGylated-based platform for efficient delivery of dietary antioxidants across the blood–brain barrier C Fernandes, M Pinto, C Martins, MJ Gomes, B Sarmento, PJ Oliveira, ... Bioconjugate Chemistry 29 (5), 1677-1689, 2018 | 39 | 2018 |
| Antioxidant therapy, oxidative stress, and blood-brain barrier: The road of dietary antioxidants M Pinto, S Benfeito, C Fernandes, F Borges Oxidative Stress and Dietary Antioxidants in Neurological Diseases 1st …, 2020 | 19 | 2020 |
| Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles M Pinto, C Fernandes, E Martins, R Silva, S Benfeito, F Cagide, ... Pharmaceutics 11 (7), 331, 2019 | 14 | 2019 |
| Development of piperic acid-based monoamine oxidase inhibitors: synthesis, structural characterization and biological evaluation D Chavarria, F Cagide, M Pinto, LR Gomes, JN Low, F Borges Journal of Molecular Structure 1182, 298-307, 2019 | 13 | 2019 |
| Coordination compounds as multi-delivery systems for osteoporosis JS Barbosa, M Pinto, S Barreiro, C Fernandes, RF Mendes, P Lavrador, ... ACS Applied Materials & Interfaces 13 (30), 35469-35483, 2021 | 10 | 2021 |
| Antioxidant Therapy and Neurodegenerative Disorders: Lessons From Clinical Trials C Silva, M Pinto, C Fernandes, S Benfeito, F Borges Systems Medicine: Integrative, Qualitative and Computational Approaches 2 …, 2020 | 8 | 2020 |
| Rescuing a Troubled Tolcapone with PEGylated PLGA Nanoparticles: Design, Characterization, and Hepatotoxicity Evaluation M Pinto, CS Machado, S Barreiro, FJ Otero-Espinar, F Remião, F Borges, ... ACS Applied Materials & Interfaces 16 (17), 21522-21533, 2024 | 3 | 2024 |
| Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D Permeability … CS Machado, M Pinto, B Aguiar, S Costa, B Sarmento, FJ Otero Espinar, ... ACS Applied Materials & Interfaces 16 (43), 58299-58312, 2024 | 2 | 2024 |
| Cellular and Mitochondrial Toxicity of Tolcapone, Entacapone, and New Nitrocatechol Derivatives M Pinto, TB Silva, VA Sardão, R Simões, B Albuquerque, PJ Oliveira, ... ACS Pharmacology & Translational Science 7 (5), 1637-1649, 2024 | 2 | 2024 |
| Rescuing a troubled tolcapone: nanomedicine on hepatotoxicity fight club MRV Pinto, S Barreiro, R Silva, F Remiao, F Borges, C Fernandes Toxicology Letters 350, S165-S166, 2021 | | 2021 |
| Bioavailability improvement of a monoamine oxidase-B inhibitor using PEGylated PCL-based nanoparticles M Pinto, C Fernandes, E Gil-Martins, R Silva, S Benfeito, F Cagide, ... TOXICOLOGY LETTERS 314, S205-S206, 2019 | | 2019 |
